PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

1. Prospective Intraindividual Comparison of Ga-68 PSMA and F-18 FDG Dual-Tracer PET/CT Imaging in Evaluation of High-Grade Prostate Cancer.World journal of nuclear medicine · 2026
   Article
2. Quantitative Assessment of Brain Glucose Metabolism Using Dynamic Glucose-Enhanced Magnetic Resonance Fingerprinting (DGE-MRF).Chemical & biomedical imaging · 2026
   Article
3. The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance.Translational lung cancer research · 2026
   Review
4. Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.BMC cancer · 2026
   Article
5. Development and validation of a radiogenomics prognostic model integrating PET/CT radiomics and glucose metabolism-related gene signatures for non-small cell lung cancer.European journal of nuclear medicine and molecular imaging · 2025
   Article
6. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate.Prostate cancer and prostatic diseases · 2024
   Article
7. Prognostic value of [Annals of medicine · 2024
   Article
8. Metabolic adaptations in prostate cancer.British journal of cancer · 2024
   Review
9. Enhanced detection of skull-base bone invasion in nasopharyngeal carcinoma: the supplementary diagnostic value ofQuantitative imaging in medicine and surgery · 2024
   Article
10. Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types.Molecular biology reports · 2024
    Review
11. The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target.BMC cancer · 2024
    Review
12. The role of RNA modification in urological cancers: mechanisms and clinical potential.Discover oncology · 2023
    Review
13. Metabolically regulated lineages in prostate cancer.Nature cell biology · 2023
    Article
14. The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer.Biomedicines · 2022
    Review
15. Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.Cells · 2022
    Review
16. Beyond the Prognostic Value of 2-[Diagnostics (Basel, Switzerland) · 2022
    Review
17. PET Use in Cancer Diagnosis, Treatment, and Prognosis.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
18. Propionic Acid-Based PET Imaging of Prostate Cancer.Molecular imaging and biology · 2021
    Article
19. Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
20. Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro.Cancers · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

Indexed as